Drug
Imc P115c
Imc P115c: highest development phase Phase 1, developed by Immunocore. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Immunocore
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMC-P115C NCT07156136 | Phase 1 | PRAME Positive |
Latest
No recent events.
Follow Imc P115c on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.